Molecular ecology of marine isoprene degradation

Isoprene is an atmospheric trace gas whose emissions to the atmosphere are roughly equal to that of methane. It is highly reactive and has the potential to affect climate through a variety of interactions in the atmosphere, including the formation of ozone. In the marine environment alone, algae produce up to 11 Tg y-1 of isoprene. To date, little is known about its degradation by microbes in the marine environment. In this project, isoprene-degrading bacteria from a range of marine sites were characterised and Illumina sequencing was used to mine the genomes of isoprene-degrading strains related to Gordonia polyisoprenivorans and Mycobacterium hodleri, isolated from the Colne Estuary, Essex. From these genomes, we retrieved novel sequences encoding isoprene monooxygenase, previously identified in a terrestrial Rhodococcus species. This information allowed the design of specific PCR primer sets for the isoA gene, encoding the alpha subunit of isoprene monooxygenase, to retrieve isoprene-specific genes from environmental samples. The primers amplify isoA from a wide range of marine genera. A database of isoA sequences from extant isoprene degraders and isoA sequences retrieved by PCR from DNA from a variety of different marine environments was created. The data obtained demonstrated that isoprene monooxygenase genes are widespread in the marine environment. Other work focused on the physiology of isoprene-degrading bacteria, particularly the marine isolate Gordonia polyisoprenivorans. SDS-PAGE, oxygen electrode assays and RT-PCR were also used to investigate the regulation of soluble diiron centre monooxygenases in this organism, and showed that two separate, inducible monooxygenase enzyme systems exist in this organism and are responsible for the oxidation of isoprene and propane. DNA-Stable Isotope Probing revealed that members of the genera Rhodococcus, Mycobacterium, Gordonia and Microbacterium are active isoprene degraders in the Colne Estuary

Giant pulmonary artery aneurysm in a patient with vasoreactive pulmonary hypertension: a case report

<p>Abstract</p> <p>Background</p> <p>Pulmonary artery aneurysms are a rare condition, frequently associated with pulmonary hypertension. However, the evolution and treatment of this pathology is still not clear.</p> <p>Case Presentation</p> <p>The authors report a case of a 65-year old patient with pulmonary artery aneurysm associated with pulmonary arterial hypertension. Due to a positive vasoreactivity test, treatment with calcium channel blockers was started with near normalization of the right cardiac pressures. Nevertheless, after 20 months of treatment, the pulmonary artery aneurysm size remained unchanged with an associated severe pulmonary regurgitation and causing extrinsic compression of the main left coronary artery. Surgical correction was successfully performed.</p> <p>Conclusions</p> <p>This is the first case report of a pulmonary artery aneurysm described to be associated with vasoreactive pulmonary hypertension in a living patient. Although medical therapy for pulmonary hypertension was started, surgical correction of the aneurysm was executed in order to prevent its future complications.</p

Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits

Background: Around half million new cases of cervical cancer arise each year, making the development of an effective therapeutic vaccine against HPV a high priority. As the E6 and E7 oncoproteins are expressed in all HPV-16 tumour cells, vaccines expressing these proteins might clear an already established tumour and support the treatment of HPV-related precancerous lesions. Methods: Three different immunisation regimens were tested in a pre-clinical trial in rabbits to evaluate the humoral and cell-mediated responses of a putative HPV-16 vaccine. Fowlpoxvirus (FP) recombinants separately expressing the HPV-16 E6 (FPE6) and E7 (FPE7) transgenes were used for priming, followed by E7 protein boosting. Results: All of the protocols were effective in eliciting a high antibody response. This was also confirmed by interleukin-4 production, which increased after simultaneous priming with both FPE6 and FPE7 and after E7 protein boost. A cell-mediated immune response was also detected in most of the animals. Conclusion: These results establish a preliminary profile for the therapy with the combined use of avipox recombinants, which may represent safer immunogens than vaccinia-based vectors in immuno-compromised individuals, as they express the transgenes in most mammalian cells in the absence of a productive replication

Biological responses to change in Antarctic sea ice habitats

Sea ice is a key habitat in the high latitude Southern Ocean and is predicted to change in its extent, thickness and duration in coming decades. The sea-ice cover is instrumental in mediating ocean–atmosphere exchanges and provides an important substrate for organisms from microbes and algae to predators. Antarctic krill, Euphausia superba, is reliant on sea ice during key phases of its life cycle, particularly during the larval stages, for food and refuge from their predators, while other small grazers, including copepods and amphipods, either live in the brine channel system or find food and shelter at the ice-water interface and in gaps between rafted ice blocks. Fish, such as the Antarctic silverfish Pleuragramma antarcticum, use platelet ice (loosely-formed frazil crystals) as an essential hatching and nursery ground. In this paper, we apply the framework of the Marine Ecosystem Assessment for the Southern Ocean (MEASO) to review current knowledge about relationships between sea ice and associated primary production and secondary consumers, their status and the drivers of sea-ice change in this ocean. We then use qualitative network modelling to explore possible responses of lower trophic level sea-ice biota to different perturbations, including warming air and ocean temperatures, increased storminess and reduced annual sea-ice duration. This modelling shows that pelagic algae, copepods, krill and fish are likely to decrease in response to warming temperatures and reduced sea-ice duration, while salp populations will likely increase under conditions of reduced sea-ice duration and increased number of days of >0°C. Differences in responses to these pressures between the five MEASO sectors were also explored. Greater impacts of environmental pressures on ice-related biota occurring presently were found for the West and East Pacific sectors (notably the Ross Sea and western Antarctic Peninsula), with likely flow-on effects to the wider ecosystem. All sectors are expected to be impacted over coming decades. Finally, we highlight priorities for future sea ice biological research to address knowledge gaps in this field

Erratum to: Methods for evaluating medical tests and biomarkers

[This corrects the article DOI: 10.1186/s41512-016-0001-y.]

Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors

Context Germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene are responsible for a subset of familial isolated pituitary adenoma (FIPA) cases and sporadic pituitary neuroendocrine tumors (PitNETs). Objective To compare prospectively diagnosed AIP mutation-positive (AIPmut) PitNET patients with clinically presenting patients and to compare the clinical characteristics of AIPmut and AIPneg PitNET patients. Design 12-year prospective, observational study. Participants & Setting We studied probands and family members of FIPA kindreds and sporadic patients with disease onset ≤18 years or macroadenomas with onset ≤30 years (n = 1477). This was a collaborative study conducted at referral centers for pituitary diseases. Interventions & Outcome AIP testing and clinical screening for pituitary disease. Comparison of characteristics of prospectively diagnosed (n = 22) vs clinically presenting AIPmut PitNET patients (n = 145), and AIPmut (n = 167) vs AIPneg PitNET patients (n = 1310). Results Prospectively diagnosed AIPmut PitNET patients had smaller lesions with less suprasellar extension or cavernous sinus invasion and required fewer treatments with fewer operations and no radiotherapy compared with clinically presenting cases; there were fewer cases with active disease and hypopituitarism at last follow-up. When comparing AIPmut and AIPneg cases, AIPmut patients were more often males, younger, more often had GH excess, pituitary apoplexy, suprasellar extension, and more patients required multimodal therapy, including radiotherapy. AIPmut patients (n = 136) with GH excess were taller than AIPneg counterparts (n = 650). Conclusions Prospectively diagnosed AIPmut patients show better outcomes than clinically presenting cases, demonstrating the benefits of genetic and clinical screening. AIP-related pituitary disease has a wide spectrum ranging from aggressively growing lesions to stable or indolent disease course

Biological responses to change in Antarctic sea ice habitats

Sea ice is a key habitat in the high latitude Southern Ocean and is predicted to change in its extent, thickness and duration in coming decades. The sea-ice cover is instrumental in mediating ocean–atmosphere exchanges and provides an important substrate for organisms from microbes and algae to predators. Antarctic krill, Euphausia superba, is reliant on sea ice during key phases of its life cycle, particularly during the larval stages, for food and refuge from their predators, while other small grazers, including copepods and amphipods, either live in the brine channel system or find food and shelter at the ice-water interface and in gaps between rafted ice blocks. Fish, such as the Antarctic silverfish Pleuragramma antarcticum, use platelet ice (loosely-formed frazil crystals) as an essential hatching and nursery ground. In this paper, we apply the framework of the Marine Ecosystem Assessment for the Southern Ocean (MEASO) to review current knowledge about relationships between sea ice and associated primary production and secondary consumers, their status and the drivers of sea-ice change in this ocean. We then use qualitative network modelling to explore possible responses of lower trophic level sea-ice biota to different perturbations, including warming air and ocean temperatures, increased storminess and reduced annual sea-ice duration. This modelling shows that pelagic algae, copepods, krill and fish are likely to decrease in response to warming temperatures and reduced sea-ice duration, while salp populations will likely increase under conditions of reduced sea-ice duration and increased number of days of &gt;0°C. Differences in responses to these pressures between the five MEASO sectors were also explored. Greater impacts of environmental pressures on ice-related biota occurring presently were found for the West and East Pacific sectors (notably the Ross Sea and western Antarctic Peninsula), with likely flow-on effects to the wider ecosystem. All sectors are expected to be impacted over coming decades. Finally, we highlight priorities for future sea ice biological research to address knowledge gaps in this field

Genetic mechanisms of critical illness in COVID-19.

Host-mediated lung inflammation is present1, and drives mortality2, in the critical illness caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with critical illness may identify mechanistic targets for therapeutic development3. Here we report the results of the GenOMICC (Genetics Of Mortality In Critical Care) genome-wide association study in 2,244 critically ill patients with COVID-19 from 208 UK intensive care units. We have identified and replicated the following new genome-wide significant associations: on chromosome 12q24.13 (rs10735079, P = 1.65 × 10-8) in a gene cluster that encodes antiviral restriction enzyme activators (OAS1, OAS2 and OAS3); on chromosome 19p13.2 (rs74956615, P = 2.3 × 10-8) near the gene that encodes tyrosine kinase 2 (TYK2); on chromosome 19p13.3 (rs2109069, P = 3.98 ×  10-12) within the gene that encodes dipeptidyl peptidase 9 (DPP9); and on chromosome 21q22.1 (rs2236757, P = 4.99 × 10-8) in the interferon receptor gene IFNAR2. We identified potential targets for repurposing of licensed medications: using Mendelian randomization, we found evidence that low expression of IFNAR2, or high expression of TYK2, are associated with life-threatening disease; and transcriptome-wide association in lung tissue revealed that high expression of the monocyte-macrophage chemotactic receptor CCR2 is associated with severe COVID-19. Our results identify robust genetic signals relating to key host antiviral defence mechanisms and mediators of inflammatory organ damage in COVID-19. Both mechanisms may be amenable to targeted treatment with existing drugs. However, large-scale randomized clinical trials will be essential before any change to clinical practice